Jeil Pharma Holdings Inc (KRX:002620)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,930.00
-20.00 (-0.22%)
Apr 24, 2026, 3:30 PM KST
Market Cap137.09B +6.4%
Revenue (ttm)657.61B -15.7%
Net Income14.64B
EPS953.00
Shares Out15.35M
PE Ratio9.37
Forward PEn/a
Dividend50.00 (0.56%)
Ex-Dividend DateDec 29, 2025
Volume6,464
Average Volume16,721
Open8,950.00
Previous Close8,950.00
Day's Range8,810.00 - 8,950.00
52-Week Range7,440.00 - 9,920.00
Beta0.66
RSI58.74
Earnings DateMay 11, 2026

About Jeil Pharma Holdings

Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine... [Read more]

Sector Healthcare
Founded 1959
Employees 37
Stock Exchange Korea Stock Exchange
Ticker Symbol 002620
Full Company Profile

Financial Performance

Financial Statements